Comparison of Radiation Pneumonitis in Lung Cancer Patients Treated with HT versus IMRT and Circulating Lymphocyte Subsets as Predicting Risk Factors

References

• Mackie TR, Holmes T, Swerdloff S, et al. Tomotherapy: a new concept for the delivery of dynamic conformal radiotherapy. Med Phys. 1993;20(6):1709–1719. doi:10.1118/1.596958
   PubMed Web of Science ®Google Scholar
• Cattaneo GM, Dell’oca I, Broggi S, et al. Treatment planning comparison between conformal radiotherapy and helical tomotherapy in the case of locally advanced-stage NSCLC. Radiother Oncol. 2008;88(3):310–318. doi:10.1016/j.radonc.2008.06.006
   PubMed Web of Science ®Google Scholar
• Meng LL, Feng LC, Wang YL, Dai XK, Xie CB. Dosimetric comparison between helical tomotherapy and intensity-modulated radiation therapy plans for non-small cell lung cancer. Chin Med J. 2011;124(11):1667–1671.
   PubMed Web of Science ®Google Scholar
• Khalil AA, Hoffmann L, Moeller DS, Farr KP, Knap MM. New dose constraint reduces radiation-induced fatal pneumonitis in locally advanced non-small cell lung cancer patients treated with intensity-modulated radiotherapy. Acta Oncol. 2015;54(9):1343–1349. doi:10.3109/0284186X.2015.1061216
   PubMed Web of Science ®Google Scholar
• Kim K, Lee J, Cho Y, et al. Predictive factors of symptomatic radiation pneumonitis in primary and metastatic lung tumors treated with stereotactic ablative body radiotherapy. Radiat Oncol J. 2017;35(2):163–171. doi:10.3857/roj.2017.00066
   PubMedGoogle Scholar
• Kong M, Lim YJ, Kim Y, et al. Diabetes mellitus is a predictive factor for radiation pneumonitis after thoracic radiotherapy in patients with lung cancer. Cancer Manag Res. 2019;11:7103–7110. doi:10.2147/CMAR.S210095
   PubMed Web of Science ®Google Scholar
• Wu K, Xu X, Li X, et al. Radiation pneumonitis in lung cancer treated with volumetric modulated arc therapy. J Thorac Dis. 2018;10(12):6531–6539. doi:10.21037/jtd.2018.11.132
   PubMed Web of Science ®Google Scholar
• Wirsdorfer F, Jendrossek V. The role of lymphocytes in radiotherapy-induced adverse late effects in the lung. Front Immunol. 2016;7:591.
   PubMed Web of Science ®Google Scholar
• Cho O, Oh YT, Chun M, Noh OK, Lee HW. Radiation-related lymphopenia as a new prognostic factor in limited-stage small cell lung cancer. Tumour Biol. 2016;37(1):971–978. doi:10.1007/s13277-015-3888-y
   PubMedGoogle Scholar
• Ozsahin M, Crompton NE, Gourgou S, et al. CD4 and CD8 T-lymphocyte apoptosis can predict radiation-induced late toxicity: a prospective study in 399 patients. Clin Cancer Res. 2005;11(20):7426–7433. doi:10.1158/1078-0432.CCR-04-2634
   PubMed Web of Science ®Google Scholar
• Abravan A, Faivre-Finn C, Kennedy J, McWilliam A, van Herk M. Radiotherapy-related lymphopenia affects overall survival in patients with lung cancer. J Thorac Oncol. 2020;15(10):1624–1635. doi:10.1016/j.jtho.2020.06.008
   PubMed Web of Science ®Google Scholar
• Song CH, Pyo H, Moon SH, Kim TH, Kim DW, Cho KH. Treatment-related pneumonitis and acute esophagitis in non-small-cell lung cancer patients treated with chemotherapy and helical tomotherapy. Int J Radiat Oncol Biol Phys. 2010;78(3):651–658. doi:10.1016/j.ijrobp.2009.08.068
   PubMed Web of Science ®Google Scholar
• Kim Y, Hong SE, Kong M, Choi J. Predictive factors for radiation pneumonitis in lung cancer treated with helical tomotherapy. Cancer Res Treat. 2013;45(4):295–302. doi:10.4143/crt.2013.45.4.295
   PubMed Web of Science ®Google Scholar
• Yao B, Wang YD, Liu QZ. Radiation pneumonitis in non-small-cell lung cancer patients treated with helical tomotherapy. Niger J Clin Pract. 2016;19(1):25–29. doi:10.4103/1119-3077.173709
   PubMed Web of Science ®Google Scholar
• Arcangeli S, Agolli L, Portalone L, et al. Patterns of CT lung injury and toxicity after stereotactic radiotherapy delivered with helical tomotherapy in early stage medically inoperable NSCLC. Br J Radiol. 2015;88(1048):20140728. doi:10.1259/bjr.20140728
   PubMed Web of Science ®Google Scholar
• Figlia V, Mazzola R, Cuccia F, et al. Hypo-fractionated stereotactic radiation therapy for lung malignancies by means of helical tomotherapy: report of feasibility by a single-center experience. Radiol Med. 2018;123(6):406–414. doi:10.1007/s11547-018-0858-7
   PubMed Web of Science ®Google Scholar
• Mackie TR, Balog J, Ruchala K, et al. Tomotherapy. Semin Radiat Oncol. 1999;9(1):108–117. doi:10.1016/S1053-4296(99)80058-7
   PubMed Web of Science ®Google Scholar
• Chun SG, Hu C, Choy H, et al. Impact of intensity-modulated radiation therapy technique for locally advanced non-small-cell lung cancer: a secondary analysis of the NRG oncology RTOG 0617 randomized clinical trial. J Clin Oncol. 2017;35(1):56–62. doi:10.1200/JCO.2016.69.1378
   PubMed Web of Science ®Google Scholar
• Marks LB, Yorke ED, Jackson A, et al. Use of normal tissue complication probability models in the clinic. Int J Radiat Oncol Biol Phys. 2010;76(3 Suppl):S10–S19. doi:10.1016/j.ijrobp.2009.07.1754
   PubMed Web of Science ®Google Scholar
• Jo IY, Kay CS, Kim JY, et al. Significance of low-dose radiation distribution in development of radiation pneumonitis after helical-tomotherapy-based hypofractionated radiotherapy for pulmonary metastases. J Radiat Res. 2014;55(1):105–112. doi:10.1093/jrr/rrt080
   PubMed Web of Science ®Google Scholar
• Zhou Y, Yan T, Zhou X, et al. Acute severe radiation pneumonitis among non-small cell lung cancer (NSCLC) patients with moderate pulmonary dysfunction receiving definitive concurrent chemoradiotherapy: impact of pre-treatment pulmonary function parameters. Strahlenther Onkol. 2020;196(6):505–514. doi:10.1007/s00066-019-01552-4
   PubMed Web of Science ®Google Scholar
• Videtic GM, Stitt LW, Ash RB, et al. Impaired diffusion capacity predicts for decreased treatment tolerance and survival in limited stage small cell lung cancer patients treated with concurrent chemoradiation. Lung Cancer. 2004;43(2):159–166. doi:10.1016/j.lungcan.2003.08.026
   PubMed Web of Science ®Google Scholar
• Lopez Guerra JL, Gomez D, Zhuang Y, et al. Change in diffusing capacity after radiation as an objective measure for grading radiation pneumonitis in patients treated for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2012;83(5):1573–1579. doi:10.1016/j.ijrobp.2011.10.065
   PubMed Web of Science ®Google Scholar
• Torre-Bouscoulet L, Munoz-Montano WR, Martinez-Briseno D, et al. Abnormal pulmonary function tests predict the development of radiation-induced pneumonitis in advanced non-small cell lung cancer. Respir Res. 2018;19(1):72. doi:10.1186/s12931-018-0775-2
   PubMedGoogle Scholar
• Dehing-Oberije C, De Ruysscher D, van Baardwijk A, Yu S, Rao B, Lambin P. The importance of patient characteristics for the prediction of radiation-induced lung toxicity. Radiother Oncol. 2009;91(3):421–426. doi:10.1016/j.radonc.2008.12.002
   PubMed Web of Science ®Google Scholar
• Wang J, Cao J, Yuan S, et al. Poor baseline pulmonary function may not increase the risk of radiation-induced lung toxicity. Int J Radiat Oncol Biol Phys. 2013;85(3):798–804. doi:10.1016/j.ijrobp.2012.06.040
   PubMed Web of Science ®Google Scholar
• Yamagishi T, Kodaka N, Kurose Y, et al. Analysis of predictive parameters for the development of radiation-induced pneumonitis. Ann Thorac Med. 2017;12(4):252–258. doi:10.4103/atm.ATM_355_16
   PubMed Web of Science ®Google Scholar
• Zheng Y, Shi A, Wang W, et al. Posttreatment immune parameters predict cancer control and pneumonitis in stage I non-small-cell lung cancer patients treated with stereotactic ablative radiotherapy. Clin Lung Cancer. 2018;19(4):e399–e404. doi:10.1016/j.cllc.2017.12.012
   PubMed Web of Science ®Google Scholar
• Zhou P, Chen L, Yan D, et al. Early variations in lymphocytes and T lymphocyte subsets are associated with radiation pneumonitis in lung cancer patients and experimental mice received thoracic irradiation. Cancer Med. 2020;9(10):3437–3444. doi:10.1002/cam4.2987
   PubMed Web of Science ®Google Scholar
• Chen D, Patel RR, Verma V, et al. Interaction between lymphopenia, radiotherapy technique, dosimetry, and survival outcomes in lung cancer patients receiving combined immunotherapy and radiotherapy. Radiother Oncol. 2020;150:114–120. doi:10.1016/j.radonc.2020.05.051
   PubMed Web of Science ®Google Scholar
• Tang C, Liao Z, Gomez D, et al. Lymphopenia association with gross tumor volume and lung V5 and its effects on non-small cell lung cancer patient outcomes. Int J Radiat Oncol Biol Phys. 2014;89(5):1084–1091. doi:10.1016/j.ijrobp.2014.04.025
   PubMed Web of Science ®Google Scholar